← Back to headlines
Annovis Bio Regains NYSE Listing Compliance
Annovis Bio, a clinical-stage pharmaceutical company, has successfully regained compliance with the New York Stock Exchange's listing requirements.
26 May, 12:22 — 26 May, 12:22
Sources
Showing 1 of 1 sources
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
17m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
28m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
29m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
29m ago